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Abstract
Background: Women with metastatic breast cancer (MBC) have average life expectancies of about 2 years, and
report high levels of disease-related symptoms including pain, fatigue, sleep disturbance, psychological distress, and
functional impairment. There is growing recognition of the limitations of medical approaches to managing such
symptoms. Yoga is a mind-body discipline that has demonstrated a positive impact on psychological and
functional health in early stage breast cancer patients and survivors, but has not been rigorously studied in
advanced cancer samples.
Methods: This randomized controlled trial examines the feasibility and initial efficacy of a Mindful Yoga program,
compared with a social support condition that controls for attention, on measures of disease-related symptoms
such as pain and fatigue. The study will be completed by December 2017. Sixty-five women with MBC age ≥ 18 are
being identified and randomized with a 2:1 allocation to Mindful Yoga or a support group control intervention.
The 120-min intervention sessions take place weekly for 8 weeks. The study is conducted at an urban tertiary care
academic medical center located in Durham, North Carolina. The primary feasibility outcome is attendance at
intervention sessions. Efficacy outcomes include pain, fatigue, sleep quality, psychological distress, mindfulness and
functional capacity at post-intervention, 3-month follow-up, and 6-month follow-up.
Discussion: In this article, we present the challenges of designing a randomized controlled trial with long-term
follow-up among women with MBC. These challenges include ensuring adequate recruitment including of
minorities, limiting and controlling for selection bias, tailoring of the yoga intervention to address special needs,
and maximizing adherence and retention. This project will provide important information regarding yoga as an
intervention for women with advanced cancer, including preliminary data on the psychological and functional
effects of yoga for MBC patients. This investigation will also establish rigorous methods for future research into
yoga as an intervention for this population.
Trial registration: ClinicalTrials.gov identifer: NCT01927081, registered August 16, 2013
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Background
Although metastatic breast cancer (MBC) is a terminal
illness, the development of more effective and better
tolerated therapies has led to improved prognosis, with
average life expectancies of 2 years or more. Nonethe-
less, women with MBC continue to report poor quality
of life and high levels of pain and other disease-related
symptoms including fatigue, sleep disturbance, psycho-
logical distress, and functional impairment [1]. Coping
with these symptoms in the context of a life-limiting dis-
ease is very challenging [2, 3]. There is growing recogni-
tion of the limitations of medical approaches to managing
cancer pain and related symptoms, and heightened inter-
est in the role that self-management interventions can
play in cancer symptom control [4]. Considering the
challenging course of MBC along with the high prevalence
of pain and associated symptoms and impairments, it is
critical to develop effective interventions to enhance the
quality of the remaining years of these women’s lives.
Recently there has been a growing interest in incorp-
orating mind/body practices such as yoga and tai chi to
help cancer patients cope with disease-related symptoms
[5, 6]. The Office of Cancer Complementary and Alter-
native Medicine has prioritized studies of yoga and other
mind/body therapies, as has the National Center for
Complementary and Integrative Health [7, 8]. Yoga has
been practiced in India for its proposed physical and men-
tal benefits for thousands of years [9]. Yoga (which means
‘union’ in Sanskrit) aims at uniting mind and body
through a variety of strategies such as practicing poses
that promote strength, balance and flexibility [10–12];
breathing techniques that have soothing and energizing
effects [13, 14]; and meditation to develop mental calm
and emotional clarity [15].
Over the last several decades yoga interventions have
been demonstrated to positively impact a variety of med-
ical conditions, including hypertension [16, 17], asthma
[18], multiple sclerosis [19], tuberculosis [20], back pain
[21, 22], fibromyalgia [23, 24], and neck pain [25]. Yoga
has also shown promise for improving cancer-related symp-
toms such as fatigue and stress [26]. However prior studies
in cancer patients have been largely limited to early stage
breast cancer patients and survivors. Thus far, five system-
atic reviews of randomized controlled trials (RCTs) of yoga
for cancer have been published [27–31]. Three reviews
included meta-analyses [27, 28, 30], and one of the
remaining two focused exclusively on fatigue outcomes
[31]. The number of RCTs included across the reviews
ranged from 10 to 18, with sample sizes ranging from 18 to
164. Although the research quality across these studies
varied greatly, on average the quality was relatively good
(e.g., median quality = 67%, range 22–89% [27]). Most of
the reviewed yoga interventions primarily emphasized
physical poses, supplemented by some combination of
breathing techniques, and relaxation or meditation prac-
tices. Approximately 50% of RCTs compared yoga with
wait-list control conditions, and most of the remaining
studies employed supportive care control conditions [29].
The consensus conclusion across the reviews was that
there is moderate to good evidence that, at least in the
short-term, yoga has a positive impact on psychological
health in early stage breast cancer patients and survivors.
Effect sizes for psychosocial outcomes (e.g., emotional dis-
tress, anxiety, depression, global quality of life) were mod-
erate to large, whereas for functional well-being effect
sizes were small. Fatigue improved in approximately 50%
of studies where assessed. Only one RCT—which was
conducted by the authors of this paper—assessed pain,
which improved in that study [32]. None of the studies
reported serious adverse events. Each of the available sys-
tematic reviews concluded that larger, more rigorous trials
are needed and that these trials should include methodo-
logical improvements such as better control conditions,
more physiological measures, longer term follow-up, and
a wider range of cancer populations, including those with
advanced cancer. A notable gap in the yoga for breast
cancer literature is the absence of RCTs among individuals
with advanced cancer. Recently, we conducted a pilot
study to test a novel 8-week Mindful Yoga intervention
designed to address the cancer-related pain, fatigue and
emotional distress experienced by women with MBC. This
intervention (previously published as ‘Yoga of Awareness’)
showed promising results in terms of effects on these
symptoms, and feasibility [33]. However, the MBC pilot
study had major limitations including the lack of a control
group, very small sample size (N = 13), and failure to ad-
dress mediators that might explain the treatment effects.
In this paper, we present the design and detailed
protocol of the first-known RCT of a yoga intervention
for patients with advanced cancer. This single-blinded,
randomized, attention-controlled, clinical trial for women
with MBC has been funded by the National Center for
Complementary and Integrative Health. Along with design
considerations, we discuss the overall challenges of this
trial as regards recruitment strategies, tailoring of the yoga
intervention, and maximizing adherence and retention.
We describe methods for addressing the theoretical and
logistical issues encountered in conducting such a trial.
Upon completion of the study, the results will be reported
in accordance with the Consolidation of Standards for
Reporting Trials (CONSORT) guidelines [34].
Methods/Design
Study Design
This is a randomized, controlled, single-blind, clinical
trial of yoga in the treatment of cancer-related pain and
associated symptoms in 65 women with metastatic
breast cancer. Given the absence of prior yoga RCTs for
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patients with advanced cancer, our aims encompass the
feasibility and acceptability of the Mindful Yoga inter-
vention in this population, as well as comparing the
efficacy of this intervention with a social support
comparison condition. Feasibility will be indicated by
our ability to meet accrual goals, and by at least 70% of
patients attending ≥ 4 of 8 sessions and providing post-
test assessments. Acceptability will be indicated by ≥ 80%
of participants reporting satisfaction with the yoga inter-
vention on a standardized measure of treatment effect-
iveness/satisfaction. Regarding efficacy, we hypothesize
that the yoga intervention will lead to reductions in pain,
fatigue, sleep disturbance, and psychological distress and
increases in functional capacity compared to a social
support intervention.
The social support comparison was chosen for several
reasons. First, we sought to address literature reviewers’
criticism of the frequent employment of treatment-as-
usual and wait-list control conditions in yoga for cancer
RCTs [27–31]. Such comparisons fail to control for any
factor other than the general passage of time. Second,
based on our prior research and reviewer’s recommenda-
tions, we determined that the most important factors to
control for were attention and time within a professionally-
guided group intervention context. We ultimately decided
on a social support comparison condition because previous
studies indicate this type of intervention is viewed as highly
credible by patients, and attendance at social support
groups is comparable to that of other intervention groups
[35–37]. Along with controlling for attention and time, this
condition controls for nonspecific treatment effects such
as general social support. The “single-blind” study design
was chosen because it was not feasible to conceal assign-
ment to the yoga intervention from participants and the
intervention instructors. However, all study investigators
and study staff involved in data collection will be masked
to treatment condition, and statisticians will remain
masked until the database is deemed final and ready for
statistical analysis. As this is a low-risk behavioral trial, we
do not foresee any circumstance under which blinded staff
members will need to be unblinded during the trial.
Outcome assessments include intervention attendance
rates, self-report measures of intervention satisfaction,
pain, fatigue, sleep quality, psychological distress, mindful-
ness, a 6 min walk test measuring functional capacity, and
treatment expectations. Assessments will be completed at
baseline, post-treatment, and 3-month and 6-month
follow-up. In addition, during the intervention period, par-
ticipants will complete brief daily diaries on alternate
weeks (4 weeks total) assessing symptoms (pain, fatigue,
positive mood, negative mood, pain catastrophizing, pain
acceptance) and yoga practice. An innovative feature of
this study is that we will utilize these daily measures to
conduct a rigorous test of two key psychological mediators
that may explain the mechanisms of treatment effects.
Pain theory and research point to two variables—pain
catastrophizing (the tendency to focus on and exaggerate
the threat value of painful stimuli and negatively evaluate
one’s own ability to deal with pain) and pain acceptance
(the willingness to experience pain and yet remain en-
gaged in meaningful life activities despite pain)—that are
likely to be particularly important in explaining the effects
of the yoga intervention on pain and pain-related out-
comes [38, 39]. Understanding the underlying mecha-
nisms of the yoga intervention’s potential effects could
have far-reaching implications for the design and evalu-
ation of future yoga interventions for conditions entailing
persistent pain.
The setting of the study is an urban tertiary care
academic medical center located in Durham, North
Carolina (Duke Cancer Institute). This study has been
reviewed and approved by the Duke Medical Center Insti-
tutional Review Board (IRB). The study will adhere to the
CONSORT guidelines for clinical trials [34]. The study
flow is presented in Fig. 1.
Study population
Participants in this study are women with age ≥ 18 who
are receiving treatment for metastatic breast cancer
(Stage IV breast cancer or recurrent metastatic breast
cancer). Participants must have a life expectancy ≥
9 months as estimated by their treating oncologist; speak
and read English; and be able to understand study proce-
dures and comply with them for the entire length of the
study period. Individuals will be excluded if they have: (a)
cognitive impairment as assessed by the 6-item Mini-
Mental Status Exam; (b) Eastern Cooperative Oncology
Group (ECOG) rating of ≥ 3 or Karnofsky Performance
Status (KPS) < 60 as rated by the oncology provider; (c)
too sick to participate, as determined by the treating
oncologist; (d) received treatment for serious psychiatric
illness (e.g., schizophrenia, severe depression) in the past
6 months; (e) current engagement in yoga practice ≥ 1 day
per week; (f) resting systolic blood pressure > 180 mm
and/or diastolic blood pressure > 100 mm, or resting heart
rate > 100 beats per minute at the baseline assessment; (g)
unable or unwilling to give written informed consent.
During the trial, all participants will continue to receive
the usual care provided by their health care providers.
Medications and treatments received during the study are
documented and examined later in data analyses, but not
restricted.
Recruitment strategies
The percentage of MBC patients that accept entry when
approached about behavioral intervention studies varies
widely in the literature, from 27% [40] to 84% [41]. Our
recruitment strategies focus on enrolling interested,
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completely informed participants, and we have projected
a modest 25% acceptance rate for the present study. To
address the significant gaps in research participation
among minorities that limit the generalizability of find-
ings, especially among African Americans (38% of the
population in Durham County, North Carolina [42]), we
are employing a variety of strategies to optimize minor-
ity participant involvement in the investigation.
Initial contact with potential participants is initiated by
each patient’s health care provider, either verbally or by
an IRB-approved introductory letter and pamphlet.
Given the rapidly expanding interest in yoga among
breast cancer patients [43], the introductory materials
describe the yoga intervention as a “self-management
discussion group + gentle exercise”, and the social sup-
port intervention as a “self-management discussion
group”, with the aim of minimizing selection bias related
to patients’ intervention preferences. This introduction
includes graphics that are inclusive of various minority
groups. Consistent with recommendations on the re-
cruitment of African-American participants for clinical
and prevention trials, particularly in oncology, we pro-
vide African-American (and all) potential participants
with an opportunity to review the information about the
study without any direct request to participate. Individ-
uals who do not refuse further contact are called by a
clinical research coordinator who has received training
in how to address the social and cultural barriers to
engaging African American cancer survivors in behav-
ioral treatment studies. The study coordinator provides
a brief scripted explanation of the study, answers any
questions, and verifies eligibility. If the patient is eligible
and chooses to participate, arrangements are made to
obtain written consent and to administer the baseline as-
sessment. As an added incentive, each participant is paid
$190 for full participation in the study to offset costs
participants might incur by participating (e.g., babysitters
during sessions) and as an honorarium for their time.
Adherence and retention strategies
Adherence and retention are crucial determinants of the
quality and interpretability of clinical trials. Obstacles to
treatment attendance when intervening with patients with
advanced disease include a variety of illness-related issues,
such as unpredictable worsening of symptoms, limited
energy, and alternate patient priorities given shortened life
expectancies. Strategies we have implemented to boost
attendance are among the best practices used in many
high quality behavioral intervention trials. These strategies
include motivational interviewing during the recruitment
phase, weekly reminder emails during the intervention
phase, prompt calls from interventionists to participants
Mindful Yoga Intervention
8 weekly 120-minute sessions 
Screening & Baseline Assessment 
Randomization (N=65),
2:1 allocation to yoga or support group
Recruiting
Support Group Intervention








Fig. 1 Study flow chart
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who missed a class, and make up sessions. Adequate ad-
herence in this trial has been defined as 70% of the partici-
pants attending full sessions (120 min each) for at least 4
of the 8 treatment sessions. This is a revision from the ini-
tial definition of adequate adherence, which specified 70%
attendance of at least 7 intervention sessions. We believe
that the revision represents a more reasonable expectation
given the severity of illness in this patient population. In
reviewing data from three previous studies of the 8-
session Mindful Yoga intervention, it was apparent that
the goal of 70% of participants attending at least 7 sessions
was likely overly ambitious [32, 33, 44]. This was achieved
in only one of the three previous studies, with a popula-
tion of much healthier women who were post-treatment
for early stage breast cancer [32].
Attrition is a recognized challenge in studying the MBC
population, given the progressive nature of the disease. To
minimize missing data, we developed a retention plan to
ensure minimal dropout due to reasons other than death
or severe disease progression. This plan has featured
minimization of participant burden, provision of partici-
pant support through the intervention protocols, solicita-
tion of information about participant difficulties and
prompt response to concerns raised, and consistent efforts
to optimize the participants’ experience of study participa-
tion. Continuous quality monitoring of retention key per-
formance indicators has allowed us to rapidly identify and
respond to problems.
Sample size
Our original sample size of 60 patients (40 intervention
and 20 control) was based mainly on the primary aim of
intervention feasibility and acceptability. While we have
increased the targeted enrollment to approximately 65
patients, statistical power to detect significant interven-
tion differences remains limited. Nonetheless, our sam-
ple size will be sufficient to conduct longitudinal
analyses of the outcome variables to inform the design
of a larger-scale, multisite trial.
Randomization
Participants are randomized with a 2:1 allocation to: (a)
Mindful Yoga, or (b) a support group control intervention.
The study statisticians (M.O. & L.S.) generated the
randomization scheme prior to the start of recruitment,
which is kept in a study database which is not accessible by
blinded study personnel. The study coordinator who exe-
cutes the randomization schedule does not have access to
the data and is not involved in the outcome assessments.
Due to the group nature of the interventions, enrollment
has proceeded in cohorts. Randomization has been strati-
fied within each cohort using variable block sizes of 3 and
6. The study coordinator informs each participant of their
assigned treatment condition following the baseline assess-
ment and ≤ 14 days prior to the start of the interventions.
We planned to conduct cohorts of 20–25 participants,
so that each intervention group (two yoga groups and
one social support group per cohort) would have
between 5 and 10 group members. After the first two
cohorts, we found that class size was an important factor
in the yoga classes, which functioned best with at least
five patients in attendance, but that class size did not
appear to impact the functionality of the social support
classes. Given that attendance at each class is usually less
than 100%, it is necessary to assign at least seven
patients to each yoga class to meet the expectation of
usually having at least five patients in attendance. This
necessitates enrolling at least 20 patients per cohort to
fill two yoga classes and one social support class.
Intervention
Both interventions consist of eight group sessions con-
ducted weekly in 120-min sessions (Fig. 1).
Mindful Yoga Program
This intervention consists of eight 120-min weekly
group sessions led by a certified yoga instructor who has
extensive experience in teaching yoga techniques to
medical patients. The Mindful Yoga Program is based in
part on the Kripalu school of yoga, which is widely
taught in the U.S. [45, 46]. Mindful Yoga can be distin-
guished from many current yoga styles in that it places
strong emphasis on developing mindfulness via substan-
tial meditation practice, breathing exercises, study of
yoga philosophy, practitioner meetings, and informal ap-
plication of mindful awareness in daily life [26]. Mindful-
ness entails strategies for developing greater moment-to-
moment presence of mind, along with acceptance of and
willingness to learn from stressful experiences, so as to
begin to recognize clearly what choices contribute to
more wellbeing versus suffering [39, 47, 48]. Accord-
ingly, during posture exercises Mindful Yoga intensively
highlights the inner dimensions of practice—such as
nonreactive monitoring of sensory, mental and emo-
tional fluctuations—along with proper alignment and
breathing techniques. The yoga instructor follows a de-
tailed intervention manual (Carson JW, Carson KM:
Mindful Yoga Professional Training Manual, unpub-
lished). Each session includes gentle postures (approx.
40 min), breathing techniques (10 min), meditation
(25 min), presentations on the application of yogic prin-
ciples to optimal coping (e.g., mind/body stress reac-
tions; 20 min), and group discussions (e.g., experiences
during meditation; 25 min). The yoga poses included in
this protocol carry no more risk of injury than everyday
activities such as climbing stairs. They have been specif-
ically selected and tailored to meet the needs of women
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with MBC, and the instructor emphasizes gentle per-
formance. Patients are supplied with yoga mats, eye pil-
lows, and bolsters for doing poses. Participants are
encouraged to practice yoga techniques at home, 15–30
min per day, 5–6 days per week, guided by professionally
produced video recordings. Participants also receive brief
session summary handouts each week, which include in-
structions for the informal application of yoga practice
to daily life (e.g., in-the-moment acceptance of pain).
Social support comparison condition
This intervention consists of eight 120-min weekly group
sessions led by a licensed clinical social worker experienced
in leading groups and in working with patients with
advanced cancer. The scheduling of the sessions is identical
to that for the yoga intervention. The social support inter-
vention is modeled after the protocol utilized by Breitbart
and colleagues, and the therapist follows a detailed
treatment manual [35]. The sessions focus on discussion of
issues and themes that emerge for patients coping with
MBC, including the following: coping with medical tests;
communicating with healthcare providers; coping with
family and friends; vocational issues; body image and phys-
ical functioning concerns; fears about future physical or
psychological changes, recurrence, and mortality; and plans
for the future. Utilizing a supportive approach, the therapist
focuses on encouraging patients to share concerns related
to the cancer diagnosis and treatment, to describe their ex-
periences and emotions related to these experiences, to
voice problems that they have in coping with cancer, and to
offer support and advice to other group members.
Measures
All participants complete assessments at baseline, post-
treatment, and 3-month and 6-month follow-up (see
Table 1). In addition, they complete daily diary measures
during alternating weeks during the intervention period
assessing symptoms and yoga practice (for those in the
yoga condition).
Attendance
Attendance and time spent at each session are recorded
by having participants sign in and out of each session,



















Brief Pain Inventory-Short Form X X X X
Brief Fatigue Inventory X X X X
Pittsburg Sleep Quality Index X X X X
Hospital Anxiety & Depression
Scale
X X X X
Mindfulness questionnaire
(FFMQ-SF)
X X X X
Complementary/alternative
medicine use
X X X X
6-min Walk Test X X X X
Medical record review X X X X X
ECOG or KPS X
Demographics X
Daily diary items X X
Medication log X X X X X
Health questionnaire X
Treatment expectations X X
Adverse events X X X X X X X
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including the precise time at which they enter and leave.
The interventionist verifies the times recorded.
Satisfaction with intervention
This is assessed with the 8-item Client Satisfaction
Questionnaire-8, a briefer version of the larger Client
Satisfaction Questionnaire [49]. This measure is frequently
used to assess participants’ satisfaction with, and impres-
sion of the effectiveness of, the services they received.
Items are rated on a four-point scale. This measure has
good reliability (alpha coefficient = .93). It is administered
at the post-treatment assessment only.
Pain
Pain is assessed with the Brief Pain Inventory-Short Form,
a 9-item self-report measure that assesses worst, least, and
average levels of pain and the degree which pain interferes
in activities, mood, relationships, sleep, and enjoyment of
life. This measure is widely used with cancer patients, has
evidence of reliability and validity, and is considered the
preferred method of assessing pain endpoints [50, 51].
Fatigue
The Brief Fatigue Inventory assesses self-reported levels
of current, worst, and usual fatigue, and interference due
to fatigue. The measure consists of 9 items on which re-
spondents choose a number from 0 to 10 to rate each
item on the scale. Factor analysis has shown that 75% of
the variance on the Brief Fatigue Inventory can be ex-
plained by a single factor suggesting that it measures a
single construct. This measure has also shown good evi-
dence of concurrent and discriminant validity as well as
excellent internal consistency (alpha = .96.) [52].
Sleep quality
Sleep quality is assessed by the Pittsburgh Sleep Quality
Index, a 19-item self-report measure that produces a total
sleep quality score and seven sleep component scores
[53]. Higher scores indicate poorer sleep quality. The scale
has been widely used with breast cancer patients with
internal consistency for the total scale reported as .78 [54].
Psychological distress
The Hospital Anxiety and Depression Scale (HADS) is
used to assess depression and anxiety symptoms. The
HADS is a 14-item, 2-domain (depression and anxiety)
scale with evidence of reliability, validity, and responsive-
ness among cancer patients [55, 56]. Domain scores ≥ 8
indicate either likely depression or anxiety.
Mindfulness
The Five Facet Mindfulness Questionnaire-Short Form
(FFMQ-SF) assesses different aspects of mindfulness
[57]. The FFMQ-SF is a 24-item short form of the Five
Facet Mindfulness Questionnaire, a comprehensive
measure for assessing mindfulness [58]. The FFMQ-SF
has demonstrated reliability and validity as well as
sensitivity to change in samples of adults with anxiety
and depression as well as fibromyalgia [57].
Functional capacity
Patients’ functional capacity is assessed by the 6-min
Walk Test administered in a measured corridor accord-
ing to American Thoracic Society (ATS) guidelines [59].
Patients are instructed to walk at their fastest pace and
to cover the longest possible distance over 6 min. This
test has been shown to be a reliable and sensitive
measure of functional capacity in deconditioned clinical
populations and a sensitive test to assess therapeutic re-
sponse. The test has been successfully used in several
prior studies of cancer patients, including patients with
advanced disease, with no adverse events [60]. This test
has been shown to be a strong predictor of all-cause
mortality in lung cancer patients [61].
Daily pain, fatigue, positive mood, negative mood, pain
catastrophizing, and pain acceptance
Daily variation in pain, fatigue, positive mood, and nega-
tive mood is each assessed with a single 0-9 scale item.
Similar numeric scales are extensively used in clinical
and research settings to measure subjective phenomena
and have been found to be valid and reliable [62]. Pain
catastrophizing is measured using a well-validated two
item measure rated on a 0–6 scale [63]. Pain acceptance
is measured using two items from the Chronic Pain Ac-
ceptance Questionnaire (CPAQ), the only well-validated
measure of pain acceptance [64]. The two CPAQ items
were chosen based on their high loadings on each of the
CPAQ’s two subscales, willingness to experience pain
and engaging in activities despite pain [65].
Treatment expectations
We will examine treatment expectations using the 9-item
Outcome Expectations for Exercise Scale, in which partici-
pants are asked to rate their agreement with potential
benefits of physical activity measured on a 5-point Likert-
type scale, with 1 indicating no expectations and 5 the
highest expectations for exercise. Validity and reliability
has been previously established for this measure [66].
Safety
Study participants are monitored weekly during the inter-
vention period for the occurrence of adverse events, and
at each assessment (baseline, post-treatment, 3 months
follow-up, and 6 months follow-up). An adverse event is
defined as any unfavorable and unintended diagnosis,
symptom, sign (including an abnormal laboratory finding),
syndrome or disease which either occurs during the study,
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having been absent at baseline, or if present at baseline,
appears to worsen. Adverse events are recorded regardless
of their relationship to the study intervention. Solicited
adverse events include psychological distress (HADS
score ≥ 15), and heart rate, blood pressure, and oxygen sat-
uration collected during the 6-min Walk Test. In addition,
information about muscle soreness is collected at each
session of the yoga intervention.
Statistical analysis
The primary outcome related to feasibility is attendance,
which is measured weekly at each intervention session.
Adequate feasibility will be indicated by at least 70% of
patients attending ≥ 4 of 8 sessions. The primary outcome re-
lated to acceptability is quantified by the Client Satisfaction
Questionnaire-8 as assessed at the post-intervention evalu-
ation. Adequate acceptability of the yoga intervention will be
indicated by ≥ 80% of participants reporting a mean satisfac-
tion score ≥ 3. Secondary outcomes are measurements of
change at the post-treatment, 3-month follow-up, and 6-
month follow-up evaluations in pain, fatigue, sleep quality,
psychological distress, mindfulness and functional capacity.
These will be analyzed both as individual time points and in
longitudinal analyses. Treatment expectations—including po-
tential pre-randomization selection biases regarding the yoga
intervention—will be controlled in analyses with the data
from the measure assessing outcomes expectations [66]. We
will apply the intent-to-treat assumption for all analyses.
We will also explore within-person associations between
yoga practice, outcomes (pain, fatigue, mood) and mediators
(pain catastrophizing, pain acceptance) among participants
in the yoga condition. Multilevel random effects models will
be used to evaluate these associations, with individuals’
mean levels of yoga practice as a control variable, and prac-
tice rates person-centered to control for potentially spurious
within-person associations [67]. Multilevel modeling is an
advanced methodology for integrating data from multiple
levels of sampling, such as this study’s two levels (within-
persons and between-persons). Multilevel models are
particularly advantageous in analyzing data sets with many
repeated measures, such as daily diary records [68, 69]. By
preserving the rich detail in each individual’s full data set,
multilevel models allow for a sensitive independent
determination of day-to-day interrelated happenings for
each patient, as well as aggregation of individual estimates
for reliable results for the average patient. Multilevel models
also enable strict control for potential confounds, such as
serial autocorrelation in measurements.
Discussion
In this report we have summarized the challenges of
designing a randomized controlled trial of a yoga interven-
tion for metastatic breast cancer patients with long-term
follow-up. The challenges we faced in this design included
ensuring adequate recruitment including of minorities, lim-
iting and controlling for selection bias, tailoring of the yoga
intervention, and maximizing adherence and retention.
This project will provide important information regarding
the feasibility and acceptability of yoga as an intervention
for women with advanced cancer, and valuable preliminary
data on the psychological and functional effects of yoga for
MBC patients, including the first systematic evaluation of
the psychological mechanisms by which a yoga intervention
may produce pain relief. This investigation will also estab-
lish rigorous methods for future research for testing the
mechanisms by which yoga may affect pain, fatigue, emo-
tional distress, and functional capacity in this population.
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